Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs1057518775
rs1057518775
C 0.700 GeneticVariation CLINVAR

dbSNP: rs193922479
rs193922479
T 0.700 GeneticVariation CLINVAR

dbSNP: rs587777732
rs587777732
T 0.700 CausalMutation CLINVAR

dbSNP: rs886041065
rs886041065
T 0.700 CausalMutation CLINVAR

dbSNP: rs1801282
rs1801282
0.090 GeneticVariation BEFREE Pro12Ala, a missense mutation in exon 2 of PPARG, reduces transcriptional activity of PPARgamma2 and is shown to be associated with increased insulin sensitivity and protection from T2D. 20368233

2010

dbSNP: rs1805192
rs1805192
0.090 GeneticVariation BEFREE Pro12Ala, a missense mutation in exon 2 of PPARG, reduces transcriptional activity of PPARgamma2 and is shown to be associated with increased insulin sensitivity and protection from T2D. 20368233

2010

dbSNP: rs1801282
rs1801282
0.090 GeneticVariation BEFREE A common polymorphism (Pro12Ala) of the adipose tissue-specific gamma 2 isoform is associated with increased insulin sensitivity and decreased risk of developing type 2 diabetes. 12643137

2002

dbSNP: rs1805192
rs1805192
0.090 GeneticVariation BEFREE A common polymorphism (Pro12Ala) of the adipose tissue-specific gamma 2 isoform is associated with increased insulin sensitivity and decreased risk of developing type 2 diabetes. 12643137

2002

dbSNP: rs587777260
rs587777260
0.020 GeneticVariation BEFREE A female presenting at age 11 years with acanthosis nigricans and extreme postprandial hyperinsulinemia was heterozygous for a premature stop mutation (R363X) in TBC1D4. 19470471

2009

dbSNP: rs148969251
rs148969251
0.010 GeneticVariation BEFREE A functional Tyr1306Cys variant in LARG is associated with increased insulin action in vivo. 16644711

2006

dbSNP: rs776234219
rs776234219
0.010 GeneticVariation BEFREE A novel mutation in IGFALS, c.380T>C (p.L127P), associated with short stature, delayed puberty, osteopenia and hyperinsulinaemia in two siblings: insights into the roles of insulin growth factor-1 (IGF1). 23488611

2013

dbSNP: rs866477740
rs866477740
0.010 GeneticVariation BEFREE A novel mutation in IGFALS, c.380T>C (p.L127P), associated with short stature, delayed puberty, osteopenia and hyperinsulinaemia in two siblings: insights into the roles of insulin growth factor-1 (IGF1). 23488611

2013

dbSNP: rs373115603
rs373115603
SDS
0.010 GeneticVariation BEFREE A novel mutation in IGFALS, c.380T>C (p.L127P), associated with short stature, delayed puberty, osteopenia and hyperinsulinaemia in two siblings: insights into the roles of insulin growth factor-1 (IGF1). 23488611

2013

dbSNP: rs225014
rs225014
0.010 GeneticVariation BEFREE A single-nucleotide polymorphism in D2 (Thr92Ala) has been associated with increased insulin resistance in nondiabetic and type 2 diabetes (DM2) subjects. 20566590

2010

dbSNP: rs1801282
rs1801282
0.090 GeneticVariation BEFREE Among the genetic factors, a polymorphism (Pro12Ala) in the peroxisome proliferator-activated receptor (PPAR) gamma is associated with a reduced risk of type 2 diabetes mellitus and increased insulin sensitivity, primarily that of lipolysis. 11684868

2001

dbSNP: rs1805192
rs1805192
0.090 GeneticVariation BEFREE Among the genetic factors, a polymorphism (Pro12Ala) in the peroxisome proliferator-activated receptor (PPAR) gamma is associated with a reduced risk of type 2 diabetes mellitus and increased insulin sensitivity, primarily that of lipolysis. 11684868

2001

dbSNP: rs11575937
rs11575937
0.030 GeneticVariation BEFREE Association between nuclear lamin A/C R482Q mutation and partial lipodystrophy with hyperinsulinemia, dyslipidemia, hypertension, and diabetes. 10810087

2000

dbSNP: rs2918419
rs2918419
0.010 GeneticVariation BEFREE Carrying Bcl1 variant alleles without rs2918419</span> was not associated with hyperinsulinaemia/insulin resistance. 18194492

2008

dbSNP: rs13266634
rs13266634
0.010 GeneticVariation BEFREE Consistent with these findings, ZnT8KO mice and human individuals carrying rs13266634, a major risk allele of SLC30A8, exhibited increased insulin clearance, as assessed by c-peptide/insulin ratio. 24051378

2013

dbSNP: rs137852671
rs137852671
0.020 GeneticVariation BEFREE Conversely, no E1506K currents were recorded at rest or after metabolic inhibition, as expected for a mutation causing hyperinsulinemia. 21617188

2011

dbSNP: rs33997857
rs33997857
0.010 GeneticVariation BEFREE Decreased expression of lipin-1 in adipose tissue correlates with increased insulin resistance, and tagging of the LPIN1 locus has shown that rs33997857, rs6744682, and rs6708316 associate with metabolic phenotypes, specifically body mass index (BMI) and fasting serum lipid levels, both on the individual single-nucleotide polymorphism level and with a three-marker haplotype. 20356931

2010

dbSNP: rs6708316
rs6708316
0.010 GeneticVariation BEFREE Decreased expression of lipin-1 in adipose tissue correlates with increased insulin resistance, and tagging of the LPIN1 locus has shown that rs33997857, rs6744682, and rs6708316 associate with metabolic phenotypes, specifically body mass index (BMI) and fasting serum lipid levels, both on the individual single-nucleotide polymorphism level and with a three-marker haplotype. 20356931

2010

dbSNP: rs11575937
rs11575937
0.030 GeneticVariation BEFREE FPLD was recently discovered to result from mutated LMNA (R482Q; OMIM #150330.0010), which is the gene encoding nuclear lamins A and C. Results from extended pedigrees indicate that dyslipidemia precedes the plasma glucose abnormalities in FPLD subjects with mutant LMNA, and that the hyperinsulinemia is present early in the course of the disease. 11122771

2000

dbSNP: rs9997745
rs9997745
0.010 GeneticVariation BEFREE GG homozygotes for rs9997745 had increased MetS risk {odds ratio (OR) 1.90 [confidence interval (CI) 1.15, 3.13]; P = 0.01}, displayed elevated fasting glucose (P = 0.001) and insulin concentrations (P = 0.002) and increased insulin resistance (P = 0.03) relative to the A allele carriers. 20176858

2010

dbSNP: rs268
rs268
LPL
0.010 GeneticVariation BEFREE Heterozygosity for Asn291-->Ser mutation in the lipoprotein lipase gene in two Finnish pedigrees: effect of hyperinsulinemia on the expression of hypertriglyceridemia. 8732773

1996